Abstract:Obiective To examine the relationships between inner ear hair cells and supporting cells from induced pluripotent stem cells (iPSCs). Methods Normal iPSCs derived from a healthy donor (C-iPS), iPSCs with myosin7A mutation derived from a deaf patient (P-iPS) and iPSCs with myosin 7A corrected genetically (CP-iPS) were induced to differentiate into otic progenitors, and then OEPs were isolated from otic progenitors and induced to differentiate into in-ner ear hair cell-like cells and supporting cells. Immunofluorescence was used to examine in vitro formation of intercel-lular junctions between the induced hair cell-like cells and supporting cells. Furthermore, EGFP-OEPs derived from three iPSCs were transplanted into the inner ear of albino Rong-Chang swine via round widow to examine the migra-tion, differentiation and intercellular junctions between these cells. Results OEPs derived from iPSCs could be induced into hair cell-like cells and supporting cells simultaneously, and intercellular junctions such as adhering junctions and tight junctions were formed between hair cell-like cells and supporting cells derived from OEPs. After transplantation, the grafted cells could migrate from the scala tympani to the scala media. However, only a limited number of cells were integrated into the native auditory epithelial tissue, and some EGFP-cells integrated into the organ of Corti and ex-pressed the hair cell marker MYO7A, indicating that these exogenous cells had differentiated into hair cell-like cells. Further immunolabeling assays showed production of adhering junction proteins (E-cadherin and N-cadherin) and a tight junction protein (ZO-1) between these differentiated cells and other cells, similar to what was observed in vitro. Conclusions Cell-cell interactions such as adhering junctions and tight junctions between hair cell-like cells and support-ing cells derived from iPSCs can be formed not only in vitro but also in vivo. These results may facilitate the develop-ment of hair cells replacement-based strategy for deafness.

Effects of Genetic Correction on the Differentiation of Hair Cell-Like Cells from Ipscs with MYO15A Mutation

Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.

Genetic Correction of TRMU Allele Restored the Mitochondrial Dysfunction-Induced Deficiencies in Ipscs-Derived Hair Cells of Hearing-Impaired Patients.

Genetic correction of induced pluripotent stem cells from a DFNA36 patient results in morphologic and functional recovery of derived hair cell-like cells

Intercellular Junctions Between Hair Cell-like Cells and Supporting Cells Derived From Human iPSCs

Verification of an Ipsc Line (Lzui002-A) from a Patient with a Novel Mutation in the TBL1X Gene.

A Novel Mutation Located in the N-Terminal Domain of MYO15A Caused Sensorineural Hearing Loss.

Gene therapy: an emerging therapy for hair cells regeneration in the cochlea

Precise Detection of CRISPR-Cas9 Editing in Hair Cells in the Treatment of Autosomal Dominant Hearing Loss

Defective mechanosensory transduction of the new inner hair cells prevents hearing recover in the damaged cochlea

Molecular Mechanisms and Potentials for Differentiating Inner Ear Stem Cells into Sensory Hair Cells.

Induction of Differentiation of Human Embryonic Stem Cells into Functional Hair-Cell-like Cells in the Absence of Stromal Cells.

Potential of Gene and Cell Therapy for Inner Ear Hair Cells

Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice

Atoh1 and Other Related Key Regulators in the Development of Auditory Sensory Epithelium in the Mammalian Inner Ear: Function and Interplay

Differentiation and transplantation of human induced pluripotent stem cell-derived otic epithelial progenitors in mouse cochlea

Generation of inner ear hair cells by direct lineage conversion of primary somatic cells

Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides

Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells

Induction of Functional Hair-Cell-Like Cells from Mouse Cochlear Multipotent Cells

Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo